The mechanisms of mTOR inhibitor overcoming cisplatin resistance.

被引：0
|
作者：
Wu, Chunjing
Wangpaichitr, Medhi
Feun, Lynn
Lampidis, Theodore
Kuo, Marcus T.
Robles, Carlos
Savaraj, Niramol
机构：
[1] Univ Miami, Miami, FL USA
[2] MD Anderson, Houston, TX USA
[3] VAMC, Miami, FL USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5434
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Overcoming cisplatin resistance by mTOR inhibitor in lung cancer
    Chunjing Wu
    Medhi Wangpaichitr
    Lynn Feun
    Marcus Tien Kuo
    Carlos Robles
    Theodore Lampidis
    Niramol Savaraj
    Molecular Cancer, 4
  • [2] Overcoming cisplatin resistance by mTOR inhibitor in lung cancer
    Wu, Chunjing
    Wangpaichitr, Medhi
    Feun, Lynn
    Kuo, Marcus Tien
    Robles, Carlos
    Lampidis, Theodore
    Savaraj, Niramol
    MOLECULAR CANCER, 2005, 4 (1)
  • [3] Overcoming mTOR resistance mutations with a new generation mTOR inhibitor
    Rodrik-Outmezguine, Vanessa S.
    Okaniwa, Masanori
    Yao, Zhan
    Novotny, Chris
    McWhirter, Claire
    Banaji, Arpitha
    Won, Helen
    Wong, Wai
    Berger, Mike
    de Stanchina, Elise
    Barratt, Derek G.
    Cosulich, Sabina
    Klinowska, Teresa
    Rosen, Neal
    Shokat, Kevan M.
    CANCER RESEARCH, 2016, 76
  • [4] Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
    Vanessa S. Rodrik-Outmezguine
    Masanori Okaniwa
    Zhan Yao
    Chris J. Novotny
    Claire McWhirter
    Arpitha Banaji
    Helen Won
    Wai Wong
    Mike Berger
    Elisa de Stanchina
    Derek G. Barratt
    Sabina Cosulich
    Teresa Klinowska
    Neal Rosen
    Kevan M. Shokat
    Nature, 2016, 534 : 272 - 276
  • [5] Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
    Rodrik-Outmezguine, Vanessa S.
    Okaniwa, Masanori
    Yao, Zhan
    Novotny, Chris J.
    McWhirter, Claire
    Banaji, Arpitha
    Won, Helen
    Wong, Wai
    Berger, Mike
    de Stanchina, Elisa
    Barratt, Derek G.
    Cosulich, Sabina
    Klinowska, Teresa
    Rosen, Neal
    Shokat, Kevan M.
    NATURE, 2016, 534 (7606) : 272 - +
  • [6] Overcoming mTOR inhibitor resistance by targeting the lysosomal deregulation
    Zhang, Shengzhe
    Lee, Sung Ho
    Nie, Litong
    Jung, Youn-Sang
    Jun, Sohee
    Zhang, Jie
    Lien, Esther M.
    Chen, Junjie
    Park, Jae-Il
    CANCER RESEARCH, 2022, 82 (04)
  • [7] Commentary: Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
    Renna, Maurizio
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [8] Overcoming mTOR resistance: Results of a phase I study of the mTOR inhibitor ridaforolimus and the HDAC inhibitor vorinostat
    Zibelman, Matthew R.
    Wong, Yu-Ning
    Malizzia, Lois
    Corrigan, Alycia
    Olszanski, Anthony J.
    Denlinger, Crystal Shereen
    Roethke, Susan K.
    Tetzlaff, Colleen H.
    Hudes, Gary R.
    Plimack, Elizabeth R.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] Mechanisms of mTOR inhibitor resistance in cancer therapy
    Carew, Jennifer S.
    Kelly, Kevin R.
    Nawrocki, Steffan T.
    TARGETED ONCOLOGY, 2011, 6 (01) : 17 - 27
  • [10] Mechanisms of mTOR inhibitor resistance in cancer therapy
    Jennifer S. Carew
    Kevin R. Kelly
    Steffan T. Nawrocki
    Targeted Oncology, 2011, 6 : 17 - 27
12345